The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, November 29, 2021
Valneva a specialty vaccine company, and IDT Biologika announced their collaboration for the production of Valneva’s inactivated COVID-19 vaccine ...
read more
Tuesday, November 23, 2021
BeiGene, Ltd., a global biotechnology company focused on developing and commercializing innovative cancer medicines worldwide, announced today that it...
read more
Monday, November 22, 2021
REGENXBIO Inc. announced the FDA granted Orphan Drug Designation for RGX-202, a potential one-time gene therapy for the treatment of Duchenne muscular...
read more
Thursday, November 18, 2021
Longeveron Inc. a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, ...
read more
Thursday, November 18, 2021
Dicerna Pharmaceuticals announced a definitive agreement with Novo Nordisk under which Novo Nordisk will acquire Dicerna, a biopharmaceutical company ...
read more
Thursday, November 18, 2021
Gilead Sciences, Inc. and Arcus Biosciences, Inc. announced that Gilead has exercised its options to three programs in Arcus’s clinical-stage ...
read more
Wednesday, November 17, 2021
The BioCapt Single-Use (BCSU) microbial impactors from Particle Measuring Systems (PMS) are now available for use with applications at 100 Liters Per ...
read more
Wednesday, November 17, 2021
ADMA Biologics, Inc. an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived ...
read more
Wednesday, November 17, 2021
Twist Bioscience Corporation has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology company to develop and ...
read more
Wednesday, November 03, 2021
GeneVentiv Therapeutics, a pre-clinical gene therapy company, announced that the FDA has granted Orphan Drug Designation (ODD) to GENV-HEM for the ...
read more
Wednesday, November 03, 2021
Avantor completed the acquisition of Masterflex bioprocessing business and related assets (collectively "Masterflex") of Antylia Scientific, a ...
read more
Wednesday, November 03, 2021
BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading ...
read more
Wednesday, November 03, 2021
Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutrition industries, announced today the acquisition of the service unit ...
read more
Monday, November 01, 2021
The FDA announced the new use of a NextGen Portal for reporting the annual amount of listed human and animal drugs and human biological products that ...
read more
Waters Corporation and Sartorius announced they will partner to provide bioprocess experts with direct access to high-quality mass spectrometry (MS) ...
read more